WALGREEN COMPANY for WALGREEN COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare reform - regarding how Walgreens and its subsidiaries can impact efforts in health care reform with regards to access, affordability and quality.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| LESLIE HIGGINS | — |
| SUSIE HOWARD | — |
| HEATHER HERNDON SMITH | — |
Medicare/Medicaid MMM
S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE HIGGINS | — |
| SUSIE HOWARD | — |
| HEATHER HERNDON SMITH | — |
Consumer Issues/Safety/Products CSP
H.R. 759 - the "Food and Drug Administration Globalization Act of 2009" - Title II - Drug and Device Safety - provisions relating to country of origin labeling for drugs and devices; H.R. 1815 the Consumer Product Safety Solutions Act Section 2 provisions relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provisions relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracking label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE HIGGINS | — |
| SUSIE HOWARD | — |
| HEATHER HERNDON SMITH | — |
Pharmacy PHA
H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| LESLIE HIGGINS | — |
| SUSIE HOWARD | — |
| HEATHER HERNDON SMITH | — |
Law Enforcement/Crime/Criminal Justice LAW
H.R. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to aid in criminal investigations; S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement regarding stolen merchandise.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LESLIE HIGGINS | — |
| SUSIE HOWARD | — |
| HEATHER HERNDON SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.